Monday, May 17, 2021
Home News Medical Cannabis News

Medical Cannabis News

Health Europa brings you the latest Medical Cannabis News from across the field of European Healthcare & Social Care Policy.

Natural versus synthetic CBD

Natural versus synthetic CBD

Richard O’Halloran, CEO of Biosportart, discusses natural versus synthetic cannabidiol (CBD) compounds for use in products and what this means for the CBD industry. CBD...
medical cannabis

Examining the future of Europe’s medical cannabis treatments

Sita Schubert, the General Secretary of the European Medicinal Cannabis Association, discusses the future of medical cannabis treatments in Europe, looking at how they...
UK policy oversight sees farmers waste millions of pounds worth of CBD

UK policy oversight sees farmers waste millions of pounds worth of CBD

A new report co-ordinated by third sector drug policy reform organisation Volteface has today been released, promising a solution to ‘draconian, pointless’ hemp legislation. The...
Groundbreaking paper sets out recommendations for UK cannabis industry

Groundbreaking paper sets out recommendations for UK cannabis industry

A groundbreaking paper has set out recommendations to facilitate a multibillion-pound UK medical cannabis industry that could create tens of thousands of jobs. The paper...
Exploring the pharmacological and placebo effects of CBD for pain

Exploring the pharmacological and placebo effects of CBD for pain

A new study has shed light on the pain-reducing effects of CBD, as well as the impact that the placebo effect may have on...
Treating hypertension with cannabis

Treating hypertension with cannabis

Ran Abuhasira of Ben-Gurion University of the Negev speaks to HEQ about the use of cannabis in treating elderly patients. In February 2021, researchers at...
medical cannabis industry

Investing in the future of the medical cannabis industry

Akerna CEO Jessica Billingsley speaks with MCN about the future of the medical cannabis industry, regarding technology, finance and cannabis policy. Jessica Billingsley, who will...
mescaline

XPhyto: Is mescaline the next big mood-modifying medicine?

Mescaline has the potential to be the next frontier in the psychedelics renaissance and represents an unprecedented opportunity to innovate a notable advancement in...
personalised cannabis medicine

Medical cannabis care in the era of personalised medicine

In the post-COVID-19 era, now more than ever, patients are critical of the healthcare they receive. Yaron Gissin, Chief Innovation Officer of the Sade...
Changing European hemp policy

Changing European hemp policy

Lorenza Romanese, Managing Director of the European Industrial Hemp Association, speaks with HEQ about the benefits of hemp and its derivatives and the need...
Medical cannabis

Impacts of recreational and medical cannabis legalisation in Canada

Dr Philippa Hawley tells Health Europa Quarterly about the effects of recreational legalisation on medical cannabis users Following the broadly successful legalisation of cannabis for...
The benefits of cannabis for treating chronic pain

The benefits of cannabis for treating chronic pain

Dr Andrew Agius, Medical Director at the Pain Clinic, speaks to HEQ about the benefits of cannabis in treating chronic pain. Cannabis has been used...
Greenheart CBD: the first CBD company to introduce DeFi token

Greenheart CBD: the first company to introduce a CBD DeFi token

Greenheart offers premium seed-to-shelf CBD and an innovative decentralised finance token. Greenheart CBD is an Irish-owned company with a vision to bring the finest Irish-made...
First medical cannabis clinic approved by Scottish regulator

First medical cannabis clinic approved by Scottish regulator

Sapphire Medical Clinics is the first medical cannabis clinic to be approved by the Scottish regulator, Healthcare Improvement Scotland. Sapphire Medical, which was the first...
Cannalean cannabis edibles for reducing cholesterol

Cannalean cannabis edibles for reducing cholesterol

Cannalean’s unique CBD formulation could help to treat dyslipidaemia, without the side effects of statins. My 52-year-old husband is usually very healthy. He exercises daily,...
Medical cannabis ‘made in Denmark’

Medical cannabis ‘made in Denmark’

How Aurora Europe is ensuring reliable access to high-quality medical cannabis for Europe and beyond. There is growing recognition in Europe and across the world...
FSA provides CBD product Novel Foods update

FSA provides CBD product Novel Foods update

The Food Standards Agency has provided an update on the criteria for the sale of CBD products in England and Wales. The previous criteria for...
Medical cannabis for endometriosis pain management

Medical cannabis for endometriosis pain management

During Endometriosis Awareness Month, Sapphire Medical Clinics discusses how medical cannabis can help manage the chronic pain associated with the condition. Endometriosis is often associated...
Cannabis medicine for refractory epileptics should be available on NHS

Cannabis medicine for refractory epileptics should be available on NHS

  In this article, Hannah Deacon, medical cannabis campaigner and Executive Director of the UK Medical Cannabis Clinicians’ Society discusses how access to Bedrolite is...
Global Cannabis industry

Advancing the global cannabis industry

At the 2020 GCI Summit, Daniel Herrera and Sebastian Palazio discussed intercontinental trade partnerships The November 2020 Global Cannabis Intelligence (GCI) summit brought together stakeholders...

Medical Cannabis eBooks

Medical Cannabis Partners

Pin It on Pinterest